MedTrace Logo

The RADIANCE CED Study

NCT07231757 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-01-09

No results posted yet for this study

Summary

The RADIANCE CED study is a prospective observational study designed to evaluate the long-term effectiveness of ultrasound renal denervation in lowering blood pressure among patients with uncontrolled hypertension. Data will be collected from electronic health records (EHRs) of Medicare-eligible patients to support generalizability of outcomes to the broader Medicare population. Individual hospital enrollment is not required for this study and IRB exemption has been received by sponsor.

Conditions

Interventions

DEVICE

Ultrasound Renal Denervation (Paradise™ Ultrasound Renal Denervation (uRDN) System)

A catheter-based system that delivers ultrasound energy to the renal sympathetic nerves.

Sponsors & Collaborators

  • ReCor Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Megan Coylewright, MD · Essentia Health

  • Amir Kaki, MD · Ascension St. John Hospital

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-21
Primary Completion
2029-12-31
Completion
2031-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07231757 on ClinicalTrials.gov